Instead, we found that Eomes+ CD8+ T cells increased significantly in dLNs of melanoma-bearing mice by the treatment with EW-7197, LY-2157299 or T-cell-specific Smad4 deletion (Fig 5A, B and Supporting Information Fig S10A–C). This evidence concerns the gene SMAD4 and melanoma.